arca biopharma inc (ABIO:NASDAQ CM)
Burton E. Sobel M.D.
Former Director, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee, ARCA biopharma, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 7 different industries.|
Dr. Burton E. Sobel M.D. was a Professor of the Department of Medicine for the University of Vermont College of Medicine since 1994 and also as a Professor of Biochemistry. Dr. Sobel served as Medical & Clinical Advisor of Synvista Therapeutics, Inc. Dr. Sobel had been the Editor of Circulation and Editor of Coronary Artery Disease since 1989. Dr. Sobel served as President-elect for the Society for Experimental Biology and Medicine. His research interest concerned was ...
11080 CirclePoint RoadPhone: 720-940-2200
Westminster, Colorado 80020
Board Members Memberships*
Former Director and Chairman of the Compensation Committee
Former Director, Member of Nominating & Corporate Governance Committee and Member of Audit Committee
Former Independent Director, Chairman of Nominating & Governance Committee and Member of Compensation Committee
Former Director, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee
Former Director, Chairman of Nominating & Governance Committee and Member of Audit Committee
Brigham and Women's Hospital
Harvard Medical School
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Jack Lief Ph.D.||Co-Founder, Chairman, Chief Executive Officer and President|
Arena Pharmaceuticals, Inc.
|Ron Squarer BSc (Biochemistry), MBA||Chief Executive Officer and Director|
Array BioPharma, Inc.
|Mark R. Baker J.D.||Chief Executive Officer, Director and Member of Science & Strategy Committee|
Progenics Pharmaceuticals, Inc.
|Aijaz Tobaccowalla||Managing Director, Additional Director, Member of Board Administrative Committee and Member of Nomination & Remuneration Committee|
|Michael L. Babich||Chief Executive Officer, President and Director|
INSYS Therapeutics, Inc.
|$1.0M||Compensation as of Fiscal Year 2013.|